A Study of the Efficacy and Safety of MK-5475 in Participants with Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007)

Trial Identifier: 5475-007
Sponsor: MSD
Start Date: May 2021
Primary Completion Date: January 2024
Study Completion Date: July 2024
Condition: Pulmonary Hypertension

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Protocol Plain Language Summary – English
Protocol Plain Language Summary – English

Trial Locations